"Chronic pain patients who use cannabis products for six months report improvements in their health-related quality of life and decreases in their daily opioid consumption, according to observational data published in the journal Expert Review of Neurotherapeutics."
"The growth in Israel’s medical cannabis industry has slowed over the past several months, but experts say regulatory changes are afoot that could reinvigorate patient numbers, if the country’s tumultuous political situation stabilizes.
Israel has one of the world’s largest medical marijuana markets.
And industry sources suggest the slight decrease in February continues a slowing trend, stemming partly, they said, from the recent arrest of a small number of psychiatrists suspected of issuing cannabis licenses without a sufficientmedical basis.
“The decline is also due to the fact that licenses can only be obtained for very specific diseases and under precise conditions,” said Oren Lebovitch, publisher of The Israeli Cannabis Magazine.
Lebovitch noted that Israeli governments have changed, frequently, in recent years.
Last fall, for example, the country held its fifth election in four years.
The frequent turnover has led to the nation's medical cannabis industry receiving inconsistent treatment from the government.
In 2020, for example, the government laid out a plan to legalize recreational cannabis, looking to Canada as a potential blueprint.
But, that plan failed to materialize because of a change in government."
"The adoption of adult-use marijuana legalization in Canada is not associated with any short-term increase in the percentage of people engaging in problematic cannabis use, according to data published in the journal Drug and Alcohol Review."
"The oral administration of a proprietary encapsulated dose of CBDreducesambulatory blood pressure in subjects suffering from either mild or moderate hypertension, according to placebo-controlled clinical trial data published in the journal Cannabis and Cannabinoid Research."
"Adults with a history of cannabis use are less likely than non-users to be diagnosed with liver steatosis (abnormal fat retention a/k/a fatty liver disease), according to data published in the journal PLOS One.
A group of Chinese investigators assessed the relationship between marijuana use and the prevalence of fatty liver disease in a cohort of 2,622 US adults. Study participants consisted of current cannabis consumers, former consumers, and lifetime non-users.
Researchers determined that both current and former users possessed lower rates of liver steatosis than did those with no history of marijuana use – a finding that is consistent with numerous other studies."
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.